Ebru Sağlam
Istanbul, Eyalet/Yerleşke, 34668, Turkey (Türkiye)
NCT Number: NCT04402996
Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role in the pathogenesis of human inflammatory diseases. Metrnl is highly expressed from the oral mucosa to the esophagus. Periodontitis is a chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. The authors think that Metrnl may play a role in the periodontitis. The aim of this study is to compare the Metrnl, IL-1β, and IL-10 levels of healthy and periodontitis individuals.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Istanbul, Eyalet/Yerleşke, 34668, Turkey (Türkiye)
Periodontitis is a destructive chronic inflammatory disease that can start with localized inflammatory reactions created by the supporting tissues surrounding the teeth against microorganisms and then result in loss of teeth. Cytokines play an important role in inflammation that occurs in periodontal disease.
Interleukine -1β ( IL-1β ) levels are associated with periodontal destruction in the pathogenesis of periodontal disease. Cytokines such as Interleukine-10 (IL-10) and transforming growth factor- β (TGF-β) have been reported to decrease periodontal disease progression rate.
Gingival crevicular fluid shows the cellular response in the periodontium. The most important host-related ingredients are inflammatory markers, including cytokines, enzymes, and interleukins. Saliva analysis is used in the diagnosis of systemic conditions as well as in the diagnosis of oral pathologies.
Meteorin- like (Metrnl) is a protein that plays a role in natural and acquired immune-related functions and inflammatory responses, and expressed in barrier tissues (skin and mucosa) as well as various macrophage populations, from dendritic cells and some granulocytes. Metrnl has proven to be an inflammatory-related immunoregulatory cytokine and shown to play a role in the pathogenesis of human inflammatory diseases. Metrnl, which is highly expressed from the oral mucosa to the esophagus, may play a role in the onset of periodontitis and an effective marker in preventing the progression of destruction. We think that Metrnl plays an important role in periodontitis, an inflammatory disease. The aim of this study is to compare the Metrnl, IL-1β, and IL-10 levels of healthy and periodontitis individuals
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
individuals' saliva samples will be collected and transferred to eppendorf tubes.
Until biochemical analysis is carried out will be stored in -80ºC.
Other names: sampling
GCF samples of individuals will be collected by paper strips and transferred to eppendorf tubes.
Until biochemical analysis is carried out will be stored in -80ºC.
Other names: sampling
Time frame: through study completion, an average of 6 months
saliva and serum levels
Time frame: through study completion, an average of 6 months
saliva and serum levels
Time frame: through study completion, an average of 6 months
saliva and serum levels
Time frame: up to 20 weeks
Silness-Löe
Time frame: up to 20 weeks
millimeter
Time frame: up to 20 weeks
Ainamo&Bay
Istanbul Saglik Bilimleri University
Other
Evaluation of Meteorin-like Levels in Individuals With Healthy and Periodontal Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06175624
Gingival Diseases, Gingivitis
Istanbul, Zeytinburnu, Turkey (Türkiye)
View Trial DetailsNCT07488403
Gingival Diseases, Gingivitis
Antalya, KONYAALTI, Turkey (Türkiye)
View Trial DetailsNCT07705048
Gingival Diseases, Gingivitis
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07628803
Gingival Diseases, Gingivitis
Bolu, Central, Turkey (Türkiye)
View Trial Details